- $469.19m
- $32.26m
- CNY2.63bn
- 71
- 71
- 67
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,511 | 3,028 | 3,206 | 2,802 | 2,631 |
Cost of Revenue | |||||
Gross Profit | 1,220 | 2,286 | 2,151 | 1,782 | 1,435 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,705 | 3,524 | 5,069 | 2,324 | 2,637 |
Operating Profit | -194 | -496 | -1,863 | 478 | -6.74 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -179 | -614 | -1,795 | 631 | 164 |
Provision for Income Taxes | |||||
Net Income After Taxes | -322 | -664 | -1,574 | 608 | 164 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -322 | -664 | -1,574 | 608 | 167 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -458 | -1,108 | -1,726 | 608 | 167 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.116 | -0.281 | -0.577 | 0.151 | 0.043 |